kg scale everolimus RAD-001 159351-69-6 for research use
9 Inquiries
159351-69-6
98%
shanghai
1g/bottle or as your requirement
2025-04-06
Octocrylene,Etocrilene,Ethylhexyl Triazone,Tris Base,DL-Homocysteinethiolactone hydrochloride,Thiodiglycolic anhydride
-
Product Description
-
Seller Information
-
Inquiry History
-
DescriptionBasic Info
-
Product Name:
Everolimus
Other Name:Rapamycin,42-O-(2-hydroxyethyl)-;23,27-Epoxy-3H-pyrido[2,1-c][1,4]oxaazacyclohentriacontine,rapamycin deriv.;42-O-(2-Hydroxyethyl)rapamycin;40-O-(2-Hydroxyethyl)rapamycin;SDZ-RAD;RAD 001;Everolimus;RAD;Certican;XIENCE V;Afinitor;Zortress;Xience;Afinitor Disperz;Votubia;1245613-55-1;2413306-61-1
CAS No.:159351-69-6
Molecular Formula:C53H83NO14
InChIKeys:InChIKey=HKVAMNSJSFKALM-GKUWKFKPSA-N
Molecular Weight:958.232
Exact Mass:958.22
EC Number:1806241-263-5
DSSTox ID:DTXSID0040599
HScode:29349990
Categories:
Characteristics-
PSA:
205 Ų
Density:1.18±0.1 g/cm3(Predicted)
Melting Point:No melting point
Boiling Point:998.7±75.0 °C(Predicted)
Flash Point:2℃
Refractive Index:1.548
Water Solubility:Soluble in dimethysulfoxide,ethanol and chloroform. Slightly soluble in water.
Storage Conditions:−20°C
Hazard IdentificationClassification of the substance or mixture
Specific target organ toxicity â repeated exposure, Category 1
GHS label elements, including precautionary statements
Pictogram(s) 
Signal word Danger
Hazard statement(s) H372 Causes damage to organs through prolonged or repeated exposure
Precautionary statement(s) Prevention P260 Do not breathe dust/fume/gas/mist/vapours/spray.
P264 Wash ... thoroughly after handling.
P270 Do not eat, drink or smoke when using this product.
Response P319 Get medical help if you feel unwell.
Storage none
Disposal P501 Dispose of contents/container to an appropriate treatment and disposal facility in accordance with applicable laws and regulations, and product characteristics at time of disposal.
Other hazards which do not result in classification
no data available
Handling and StoragePrecautions for safe handling
Handling in a well ventilated place. Wear suitable protective clothing. Avoid contact with skin and eyes. Avoid formation of dust and aerosols. Use non-sparking tools. Prevent fire caused by electrostatic discharge steam.
Conditions for safe storage, including any incompatibilities
Store the container tightly closed in a dry, cool and well-ventilated place. Store apart from foodstuff containers or incompatible materials.
-
-
Seller Information
-
Business Type:
Manufactory
-
Main Products:
Octocrylene,Etocrilene,Ethylhexyl Triazone,Tris Base,DL-Homocysteinethiolactone hydrochloride,Thiodiglycolic anhydride
-
Location:
No .41 Optics Valley Avenue, East Lake High-tech Development Zone, Wuhan ,China
-
Payment Terms:
TT against copy of documents,L/C,TT against B/L draft before shipment,100% TT in advance
-
Average lead Time:
10
-
Total Annual Revenue:
$2.5 million-$5 million
-
Total Employees:
51-100
-
Year of Establishment:
2013
-
Certifications:
Trade Mark,ISO,Trade Mark
Wuhan BJM Pharm Inc. was found in 2013, located in Hubei Province, where has long history, rich culture, convenient traffic, beautiful environment and preferential policy.
We have two factories in Dezhou , Shandong and Xianning, Hubei. The factory covers an area of 48,000 square meters with the building area of 26,000 square meters. We are specialized in the manufacture of pharmaceutical intermediates and cosmetic additives with good inspection equipments and innovative R & D capability.
In 2006, We established Lingxian Microworld Chemical New Material Co,.Ltd.
In 2008, We passed ISO9001:2008 quality system certificate
In 2013, We established Wuhan Benjamin Pharmaceutical Chemical Co.,Ltd , and obtain self-operation Import & Export right, mainly responsible for domestic and foreign business. At the same time, we set up R&D lab in Wuhan,Hubei province, can undertake various custom synthesis of intermediates and APIs.
In 2016, successfully invest to Hubei Betterorganic Technology Inc, and obtain a registered trademark “ BJM ”.
We are specialized in the R&D ,production and sales of Erdosteine intermeditae,Pirfenidone, Letrozole and related intermediates.
We stick to the principle as: people-oriented, customer first, Hope to establish a win-win business relationship with all friends
-
-
Inquiry History9 Inquiries
Country Product Purchase Quantity Date Posted 
Spain
Factory Supply Everolimus 99% 159351-69-6 raw Everolimus Powder with Fast Delivery
1 MT Oct 5, 2023 
United States
Everolimus
25 G Jan 26, 2026 
Pakistan
Everolimus
1 KG Sep 26, 2025
Pakistan
Everolimus
1 G Nov 7, 2024 
India
Everolimus
25 G Jul 17, 2025 
Russia
Everolimus API
1 KG Jul 10, 2025 
United Kingdom
everolimus
1 KG Mar 22, 2025
India
Everolimus
15 G Sep 27, 2024
Spain
Everolimus 0,2% BHT
2 MT Dec 22, 2023 Post an enquiry for this product